國立高雄大學圖資館 |

Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemicsedited by Antonio M. Esquinas.
其他作者:	Esquinas, Antonio M.
出版者:	Cham :Springer International Publishing :2023.
面頁冊數:	xxv, 487 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Artificial respiration.
電子資源:	https://doi.org/10.1007/978-3-031-29673-4
ISBN:	9783031296734$q(electronic bk.)

Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics
Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics[electronic resource] /edited by Antonio M. Esquinas. - Second edition. - Cham :Springer International Publishing :2023. - xxv, 487 p. :ill., digital ;24 cm.

PART I. NIV and ARF: Transmission, Physiopathology, Equipment and Technology -- Mechanical ventilation and history in pandemics -- Pre-hospital ARF -- Hospital Organizations -- Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation -- Rationale of Acute Respiratory Failure treatments in high risk infections -- Rationale of ARF approach in mass causalities -- Pathophysiology-High risk infections -- Nasal high flow oxygen equipment -- CPAP systems -- What Interface? -- NIV via different face masks / Helmets -- Humidification and aerosol therapy -- Models to assess air and particle dispersion -- Droplet dispersion during noninvasive oxygen therapy, nebulizer treatment and chest physic -- Part II. Summary of Clinical Experience, Guidelines, Protocols and Outcome -- NIV in Severe Acute Respiratory Syndrome (SARS) -- NIV in avian flu -- NIV in H1N1 -- NIV support in coronavirus (COVID-19) -- NIV in Acute Immunodeficiency Diseases -- NIV in Legionella pneumophila -- NIV in Tuberculosis -- NIV transplants and immunocompromised -- Nasal high flow in high risk pediatric neonatology -- Nasal high flow in high risk pediatric infections -- Guidelines and protocol -- Prognostic factors in high risk infections -- Part III. Strategies to Control Infections in Hospitals -- Negative pressure rooms or well ventilated rooms -- Bacterial and viral filters to the expiratory circuit -- Personal protection equipment for health care workers -- Part IV. Failure Noninvasive Ventilator Approach -- Failure nasal high flow oxygen in high risk infections -- NIV-Reports of national surveys in epidemic- and pandemic -- Failure of noninvasive ventilator approach in high risk infections. Key determinants -- Endotracheal intubation in high risk infections -- Airway management in failure noninvasive ventilation in high risk infections -- Radiology findings in acute respiratory failure in common high risk infections -- Part V. Procedures in NIV Approach. Guidelines, Recommendations and its Effectiveness in ARF Treatment -- Bronchoscopy and non- invasive ventilation in high risk infections -- Summary of effectiveness of NIV in the treatment of acute respiratory failure -- Part VI. NIV in the Treatment of ARF: Biological and Non-biological Mass Causalities -- Hospital Bioterrorism Response. Programs -- Influenza and other airborne infections -- Massive intoxications -- NIV in Politrauma -- Burn -- Chemical disasters -- PART VII. Outcome, Ethics, Palliative and Do Not Endotracheal Intubation -- Health Organizations guidelines -- Outcome noninvasive ventilator approach in high risk infections -- Ethical dilemmas and do not endotracheal intubation orders -- PART VIII. Future Research About NIV Approach in High Risk Infections, Mass Casualties and Pandemics -- Lessons for lasts pandemics and for the future.

The second edition of this book describes the clinical indications of NIV in patients hospitalized with high-risk infections as well as in the prehospital management of mass casualty incidents, including chemical or biological disasters and pandemics. In recent decades, we have learned the impact that different pandemics and mass casualty disasters can outcome in terms of health resource use, health costs and human lives. The development of respiratory failure in these patients, either infectious or non-infectious causes, has led to develop employment plans related both to invasive or noninvasive mechanical ventilation during acute respiratory failure.In this book authors evaluate a rational basis for indications, specific noninvasive mechanical ventilation indications in hospitalized patients (tuberculosis, bacterial, virus, etc.) and prehospital applications (mass casualty: chemical, biological disaster), equipment (ventilators, interfaces) and plan organization for health systems: how and when apply NIV. A critical review of already published studies is described as well as implications and how will be the future according to international expert opinions. Therefore, this updated edition represents a useful scientific reference point according to what it has been experienced in the last pandemics, with respect to the growing role that NIV has and must have in the world.

ISBN: 9783031296734$q(electronic bk.)

Standard No.: 10.1007/978-3-031-29673-4doiSubjects--Topical Terms:

396928
Artificial respiration.

LC Class. No.: RC740

Dewey Class. No.: 616.20046

Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics
LDR:05281nmm a2200337 a 4500 001 648842
003 DE-He213
005 20230704120550.0
006 m d
007 cr nn 008maaau
008 240116s2023 sz s 0 eng d
020 $a 9783031296734$q(electronic bk.)
020 $a 9783031296727$q(paper)
024 7 $a 10.1007/978-3-031-29673-4 $2 doi
035 $a 978-3-031-29673-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC740
072 7 $a MMKL $2 bicssc
072 7 $a MED015000 $2 bisacsh
072 7 $a MKPL $2 thema
082 0 4 $a 616.20046 $2 23
090 $a RC740 $b .N812 2023
245 0 0 $a Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics $h [electronic resource] / $c edited by Antonio M. Esquinas.
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xxv, 487 p. : $b ill., digital ; $c 24 cm.
505 0 $a PART I. NIV and ARF: Transmission, Physiopathology, Equipment and Technology -- Mechanical ventilation and history in pandemics -- Pre-hospital ARF -- Hospital Organizations -- Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation -- Rationale of Acute Respiratory Failure treatments in high risk infections -- Rationale of ARF approach in mass causalities -- Pathophysiology-High risk infections -- Nasal high flow oxygen equipment -- CPAP systems -- What Interface? -- NIV via different face masks / Helmets -- Humidification and aerosol therapy -- Models to assess air and particle dispersion -- Droplet dispersion during noninvasive oxygen therapy, nebulizer treatment and chest physic -- Part II. Summary of Clinical Experience, Guidelines, Protocols and Outcome -- NIV in Severe Acute Respiratory Syndrome (SARS) -- NIV in avian flu -- NIV in H1N1 -- NIV support in coronavirus (COVID-19) -- NIV in Acute Immunodeficiency Diseases -- NIV in Legionella pneumophila -- NIV in Tuberculosis -- NIV transplants and immunocompromised -- Nasal high flow in high risk pediatric neonatology -- Nasal high flow in high risk pediatric infections -- Guidelines and protocol -- Prognostic factors in high risk infections -- Part III. Strategies to Control Infections in Hospitals -- Negative pressure rooms or well ventilated rooms -- Bacterial and viral filters to the expiratory circuit -- Personal protection equipment for health care workers -- Part IV. Failure Noninvasive Ventilator Approach -- Failure nasal high flow oxygen in high risk infections -- NIV-Reports of national surveys in epidemic- and pandemic -- Failure of noninvasive ventilator approach in high risk infections. Key determinants -- Endotracheal intubation in high risk infections -- Airway management in failure noninvasive ventilation in high risk infections -- Radiology findings in acute respiratory failure in common high risk infections -- Part V. Procedures in NIV Approach. Guidelines, Recommendations and its Effectiveness in ARF Treatment -- Bronchoscopy and non- invasive ventilation in high risk infections -- Summary of effectiveness of NIV in the treatment of acute respiratory failure -- Part VI. NIV in the Treatment of ARF: Biological and Non-biological Mass Causalities -- Hospital Bioterrorism Response. Programs -- Influenza and other airborne infections -- Massive intoxications -- NIV in Politrauma -- Burn -- Chemical disasters -- PART VII. Outcome, Ethics, Palliative and Do Not Endotracheal Intubation -- Health Organizations guidelines -- Outcome noninvasive ventilator approach in high risk infections -- Ethical dilemmas and do not endotracheal intubation orders -- PART VIII. Future Research About NIV Approach in High Risk Infections, Mass Casualties and Pandemics -- Lessons for lasts pandemics and for the future.
520 $a The second edition of this book describes the clinical indications of NIV in patients hospitalized with high-risk infections as well as in the prehospital management of mass casualty incidents, including chemical or biological disasters and pandemics. In recent decades, we have learned the impact that different pandemics and mass casualty disasters can outcome in terms of health resource use, health costs and human lives. The development of respiratory failure in these patients, either infectious or non-infectious causes, has led to develop employment plans related both to invasive or noninvasive mechanical ventilation during acute respiratory failure.In this book authors evaluate a rational basis for indications, specific noninvasive mechanical ventilation indications in hospitalized patients (tuberculosis, bacterial, virus, etc.) and prehospital applications (mass casualty: chemical, biological disaster), equipment (ventilators, interfaces) and plan organization for health systems: how and when apply NIV. A critical review of already published studies is described as well as implications and how will be the future according to international expert opinions. Therefore, this updated edition represents a useful scientific reference point according to what it has been experienced in the last pandemics, with respect to the growing role that NIV has and must have in the world.
650 0 $a Artificial respiration. $3 396928
650 0 $a Lungs $x Diseases $x Treatment. $3 489272
650 0 $a Emergency medicine. $3 202488
650 1 4 $a Intensive Care Medicine. $3 913432
650 2 4 $a Pneumology. $3 925412
650 2 4 $a Anesthesiology. $3 274948
650 2 4 $a Emergency Medicine. $3 273861
700 1 $a Esquinas, Antonio M. $3 489783
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-29673-4
950 $a Medicine (SpringerNature-11650)